Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis—enhancing properties of psoriatic serum
1985
Using a Boyden chamber technic, we measured the directed chemotaxis of polymorphonuclear leukocytes obtained from control subjects or psoriasis patients when the leukocytes were placed in sera obtained from control subjects or psoriasis patients. The samples from patients were obtained before therapy and after 2 and 4 weeks of etretinate administration. Compared with control sera, the sera from seven untreated psoriasis patients significantly enhanced the chemotaxis of polymorphonuclear leukocytes from control subjects toward a chemotaxin (p
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
17
References
13
Citations
NaN
KQI